Skip Navigation

Japanese Journal of Clinical Oncology 2004 34(10):588-593; doi:10.1093/jjco/hyh110
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Matsui, T.
Right arrow Articles by Sakamoto, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsui, T.
Right arrow Articles by Sakamoto, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© 2004 Foundation for Promotion of Cancer Research

Sialyl Lewisa Expression as a Predictor of the Prognosis of Colon Carcinoma Patients in a Prospective Randomized Clinical Trial

Takanori Matsui1, Hiroshi Kojima2, Harumi Suzuki1, Hiroshi Hamajima1, Hiroaki Nakazato3, Katsuki Ito4, Akimasa Nakao4 and Junichi Sakamoto5

1 Department of Clinical Research, 2 Department of Gastrointestinal Surgery, Aichi Prefectural Hospital, Okazaki, Aichi, 3 Department of Surgery, Yokoyama Gastrointestinal Hospital, Nagoya, 4 Second Department of Surgery, Nagoya University, Nagoya and 5 Department of Epidemiological and Clinical Research Information Management, Kyoto University, Kyoto, Japan

For reprints and all correspondence: Takanori Matsui, Department of Clinical Research, Aichi Prefectural Hospital, 18 Kuriyado Kakemachi, Okazaki city, Aichi 444-0011, Japan. E-mail: matsui-ngy{at}umin.ac.jp

Received February 27, 2004; accepted August 16, 2004

Background: The metastatic potential of tumors is dependent on the cell to cell adhesion by cell surface carbohydrate antigens. Thus, expression of sialyl Lewisa, which is one of the important molecules of cell surface carbohydrates, may serve as a prognostic marker of aggressive and metastasizing tumor growth. However, the prognostic value of sialyl Lewisa expression in colon cancer is still controversial.

Methods: In this study, we investigated the expression of sialyl Lewisa antigen in 233 colon cancer specimens from patients who were registered in a prospective adjuvant immunochemotherapy clinical trial. The clinical course and the prognosis of the patients were evaluated after all the immunohistochemical analyses had been performed.

Results: Sialyl Lewisa expression levels were correlated with both overall survival (P = 0.0006) and disease-free survival (P = 0.004) in all patients with the log-rank test. This result could be assumed to have been influenced by the difference in the metastatic preponderance in a high versus low sialyl Lewisa expression in the tumor cells.

Conclusion: This prospective study in a randomized controlled trial suggests that sialyl Lewisa expression levels may serve as an indicator of the metastatic potential of colon cancer cells, which would strongly predict the prognosis.

Key Words: sialyl Lewisa • colon cancer • prognosis • prospective randomized clinical trial


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
GlycobiologyHome page
N. Malagolini, D. Santini, M. Chiricolo, and F. Dall'Olio
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon
Glycobiology, July 1, 2007; 17(7): 688 - 697.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.